Journal of Thrombosis and Haemostasis

FORTHCOMING ARTICLES IN THE JANUARY ISSUE
pp. xiv-xiv(1)

From γ-carboxy-glutamate to protein C
pp. 2521-2526(6)
Author: STENFLO, J.

Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: yes
pp. 2527-2529(3)
Author: COSMI, B.

Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: not yet
pp. 2530-2532(3)
Author: BAGLIN, T.

Allosteric disulfide bonds in thrombosis and thrombolysis
pp. 2533-2541(9)
Authors: CHEN, V. M.; HOGG, P. J.

Platelet activation and cardiovascular outcomes in acute coronary syndromes
pp. 2542-2543(2)
Authors: BOOS, C. J.; LIP, G. Y. H.

Platelet hyperactivity and risk of recurrent thrombosis
pp. 2544-2546(3)
Authors: HARRISON, P.; KEELING, D.

Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
pp. 2547-2552(6)
Authors: FUCHS, I.; FROSSARD, M.; SPIEL, A.; RIEDMÜLLER, E.; LAGGNER, A. N.; JILMA, B.

On the cutting edge: von Willebrand factor propeptide and thrombosis
pp. 2553-2555(3)
Author: RAGNI, M. V.

von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis
pp. 2556-2562(7)
Authors: NOSSENT, A. Y.; VAN MARION, V.; VAN TILBURG, N. H.; ROSENDAAL, F. R.; BERTINA, R. M.; VAN MOURIK, J. A.; EIKENBOOM, H. C. J.

Tackling the diabetic platelet: is high clopidogrel dosing the answer?
pp. 2563-2565(3)
Author: ANGIOLILLO, D. J.

Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel
pp. 2566-2568(3)
Authors: SIBBING, D.; VON BECKERATH, O.; SCHÖMIG, A.; KASTRATI, A.; VON BECKERATH, N.

Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome
pp. 2569-2575(7)
Authors: HULSTEIN, J. J. J.; VAN RUNNARD HEIMEL, P. J.; FRANX, A.; LENTING, P. J.; BRUINSE, H. W.; SILENCE, K.; DE GROOT, PH. G.; FIJNHEER, R.

Incidence of inhibitors in a cohort of 838 males with hemophilia A previously treated with factor VIII concentrates
pp. 2576-2581(6)
Authors: KEMPTON, C. L.; SOUCIE, J. M.; ABSHIRE, T. C.

Prothrombin A19911G polymorphism and the risk of venous thromboembolism
pp. 2582-2586(5)
Authors: MARTINELLI, I.; BATTAGLIOLI, T.; TOSETTO, A.; LEGNANI, C.; SOTTILE, L.; GHIOTTO, R.; MANNUCCI, P. M.

The association of prothrombin A19911G polymorphism with plasma prothrombin activity and venous thrombosis: results of the MEGA study, a large population-based case-control study
pp. 2587-2592(6)
Authors: CHINTHAMMITR, Y.; VOS, H. L.; ROSENDAAL, F. R.; DOGGEN, C. J. M.

Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug?
pp. 2593-2598(6)
Authors: MAUGERI, N.; GIORDANO, G.; PETRILLI, M. P.; FRATICELLI, V.; DE GAETANO, G.; CERLETTI, C.; STORTI, S.; DONATI, M. B.

Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events
pp. 2599-2606(8)
Authors: AGNELLI, G.; CIMMINIELLO, C.; MENEGHETTI, G.; URBINATI, S.

Differential regulation of protein S expression in hepatocytes and sinusoidal endothelial cells in rats with cirrhosis
pp. 2607-2615(9)
Authors: FUJII, K.; KISHIWADA, M.; HAYASHI, T.; NISHIOKA, J.; GABAZZA, E. C.; OKAMOTO, T.; UEMOTO, S.; SUZUKI, K.

A novel missense mutation responsible for factor VII deficiency in research Beagle colonies
pp. 2616-2622(7)
Authors: CALLAN, M. B.; ALJAMALI, M. N.; MARGARITIS, P.; GRIOT-WENK, M. E.; POLLAK, E. S.; WERNER, P.; GIGER, U.; HIGH, K. A.

Severe prothrombin deficiency caused by prothrombin-Edmonton (R-4Q) combined with a previously undetected deletion
pp. 2623-2628(6)
Authors: WONG, A. Y. K.; HEWITT, J.; CLARKE, B. J.; HUDSON, D. M.; KRISINGER, M. J.; DOWER, N. A.; MACGILLIVRAY, R. T. A.

Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study
pp. 2629-2635(7)
Authors: LUTSEY, P. L.; CUSHMAN, M.; STEFFEN, L. M.; GREEN, D.; BARR, R. G.; HERRINGTON, D.; OUYANG, P.; FOLSOM, A. R.

von Willebrand factor activates endothelial nitric oxide synthase in blood platelets by a glycoprotein Ib-dependent mechanism
pp. 2636-2644(9)
Authors: RIBA, R.; OBERPRIELER, N. G.; ROBERTS, W.; NASEEM, K. M.

Inhibition of adhesive and signaling functions of the platelet GPIb-V-IX complex by a cell penetrating GPIbα peptide
pp. 2645-2655(11)
Authors: DAVID, T.; OHLMANN, P.; ECKLY, A.; MOOG, S.; CAZENAVE, J.-P.; GACHET, C.; LANZA, F.

Thrombin-triggered platelet apoptosis
pp. 2656-2663(8)
Authors: LEYTIN, V.; ALLEN, D. J.; MYKHAYLOV, S.; LYUBIMOV, E.; FREEDMAN, J.

Bax activators potentiate coated-platelet formation
pp. 2664-2669(6)
Authors: DALE, G. L.; FRIESE, P.

Preconditioning ischemia attenuates molecular indices of platelet activation-aggregation
pp. 2670-2677(8)
Authors: LINDEN, M. D.; WHITTAKER, P.; FRELINGER, A. L.; BARNARD, M. R.; MICHELSON, A. D.; PRZYKLENK, K.

Early growth response transcription factor EGR-1 regulates Gαq gene in megakaryocytic cells
pp. 2678-2686(9)
Authors: JALAGADUGULA, G.; DHANASEKARAN, D. N.; KIM, S.; KUNAPULI, S. P.; RAO, A. K.

Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model
pp. 2687-2694(8)
Authors: REILLY, M. P.; TAYLOR, S. M.; FRANKLIN, C.; SACHAIS, B. S.; CINES, D. B.; WILLIAMS, K. J.; MCKENZIE, S. E.

PAR-1-dependent pp60^src activation is dependent on protein kinase C and increased [Ca²⁺]_i: evidence that pp60^src does not regulate PAR-1-dependent Ca²⁺ entry in human platelets
pp. 2695-2703(9)
Authors: HARPER, M. T.; SAGE, S. O.

Distribution and dynamic changes of sphingolipids in blood in response to platelet activation
pp. 2704-2709(6)
Authors: DAHM, F.; NOCITO, A.; BIELAWSKA, A.; LANG, K. S.; GEORGIEV, P.; ASMIS, L. M.; BIELAWSKI, J.; MADON, J.; HANNUN, Y. A.; CLAVIEN, P.-A.

Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis
pp. 2710-2715(6)
Authors: LEIK, C. E.; SU, E. J.; NAMBI, P.; CRANDALL, D. L.; LAWRENCE, D. A.

Flow-based assays for global assessment of hemostasis. Part 2: current methods and considerations for the future
pp. 2716-2717(2)
Authors: ZWAGINGA, J. J.; SAKARIASSEN, K. S.; NASH, G.; KING, M. R.; HEEMSKERK, J. W.; FROJMOVIC, M.; HOYLAERTS, M. F.

Soluble CD40 ligand in asthma patients during allergen challenge
pp. 2718-2720(3)
Authors: KOWAL, K.; PAMPUCH, A.; KOWAL-BIELECKA, O.; IACOVIELLO, L.; BODZENTA-LUKASZYK, A.

Estimation of a potentially preventable fraction of venous thromboembolism: a community-based prospective study
pp. 2720-2722(3)
Authors: NOBOA, S.; MOTTIER, D.; OGER, E.

A Bβ 14 Arg → Cys fibrinogen variant in a patient with thrombotic complications (fibrinogen St-Germain III)
pp. 2722-2723(2)
Authors: DE RAUCOURT, E.; FISCHER, A. M.; MEYER, G.; DE MAZANCOURT, P.

Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C
pp. 2724-2726(3)
Authors: GARDINER, C.; COHEN, H.; AUSTIN, S. K.; MACHIN, S. J.; MACKIE, I. J.

What causes the enhancement of activity of factor VIIa by tissue factor?
pp. 2726-2729(4)
Authors: COLINA, C. M.; VENKATESWARLU, D.; DUKE, R.; PERERA, L.; PEDERSEN, L. G.

PAR-1 activation has different effects on the angiogenic activity of endothelial progenitor cells derived from human adult and cord blood
pp. 2729-2731(3)
Authors: SMADJA, D. M.; BIÈCHE, I.; EMMERICH, J.; AIACH, M.; GAUSSEM, P.

Who is at risk for occult cancer after venous thromboembolism?
pp. 2731-2733(3)
Authors: BECKERS, M. M. J.; SCHUTGENS, R. E. G.; PRINS, M. H.; BIESMA, D. H.

Full evaluation of an acquired case of thrombotic thrombocytopenic purpura following the surgical resection of glioblastoma multiforme
pp. 2733-2737(5)
Authors: CATALAND, S. R.; JIN, M.; SMITH, E.; STANEK, M.; WU, H. M.

More on: incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational, and cross-sectional study in Brazil
pp. 2737-2738(2)
Authors: LABARERE, J.; BOSSON, J.-L.; PERNOD, G.

TALKING ABOUT…
pp. 2739-2741(3)
Authors: BRUTTOMESSO, G.; MIGLINO, N.

CORRIGENDUM
pp. 2742-2742(1)

ANNOUNCEMENTS
pp. 2745-2745(1)